Exclusive

Publication

Byline

60P launches malaria preventive medicine in Australia

Singapore, March 22 -- 60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria prevention medicine, Kodatef(R) (tafenoquine su... Read More


Philips receives recognition for design excellence

Singapore, March 22 -- Royal Philips, a global leader in health technology, recently announced that the company has received 22 prestigious awards at the iF Design Awards 2019, including an iF Design ... Read More


NUS researchers develop self-healing electronic skin

Singapore, March 22 -- Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfish to create an electronic skin with similar functionalit... Read More


Hyphens Pharma inks MoU with A*STAR for Derma research

Singapore, March 22 -- Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR's Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR's res... Read More


Psychiatry UK & Taliaz launch online service to deliver AI-driven genetic testing

Singapore, March 22 -- Taliaz, an Artificial Intelligence (AI) health-analytics startup based in Israel, and Psychiatry UK LLP (PUK), the UK's online psychiatry service, announced that they have launc... Read More


Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

Singapore, March 22 -- Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/dementia pipeline, including anti-amyloid beta (Abeta) prot... Read More


Samsung BioLogics wins CMO leadership awards in six categories

Singapore, March 22 -- Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in South Korea, is pleased to announce that Samsung has wo... Read More


PDC*line Pharma enters into a licensing agreement with LG Chem

Singapore, March 22 -- PDC*line Pharma, a biotech company developing a new class of potent and scalable antigen presenting cell, based on a proprietary cell line of Plasmacytoid Dendritic cells (PDC*l... Read More


Phar-East gathers over 700 Pharma & Biotech players across Asia

On 18, March 21 -- 20 March 2019 after a successful 2018 debut, Phar-East once again brought together experts from Asian pharma & biotechs, big pharma, regulators, payers, technology innovators and mo... Read More


Biotech firm Spiber to develop artificial hair

Singapore, March 21 -- Japanese startup Spiber has recently announced initiation of a joint research and development project using Spiber's proprietary structural proteins to create novel hair materia... Read More